Economy

Notable Price Swings:-Tetraphase Pharmaceuticals, Inc. (TTPH)

Tetraphase Pharmaceuticals, Inc. has a consensus outperform rating from 7 Wall Street analysts, and the number of shares now sold short amount to at least 5.79% of shares outstanding. (NASDAQ:AAPL) has "Outperform" rating given on Wednesday, October 28 by RBC Capital Markets.

Here are some other firms who have updated their holdings. As per Wednesday, July 26, the company rating was upgraded by Stifel Nicolaus. HC Wainwright assumed coverage on Tetraphase Pharmaceuticals in a research report on Tuesday, July 11th. They issued an "overweight" rating and a $14.00 price objective for the company.

Among 6 analysts covering Aratana Therapeutics (NASDAQ:PETX), 5 have Buy rating, 0 Sell and 1 Hold. Needham & Company LLC reiterated a "hold" rating on shares of Tetraphase Pharmaceuticals in a research report on Thursday, July 27th. The value of the investment in Tetraphase Pharmaceuticals, Inc increased from $113,000 to $411,000 increasing 263.7% since the last quarter.

Equity analyst PiperJaffray released its first research report on the stock with an initial rating of "Overweight". Tetraphase Pharmaceuticals, Inc.is based in Watertown, Massachusetts. The stock's market cap is $346.65 million.

Company chares are trading at $7.15 which is slightly above the 50 day moving average of $6.50 and a tad under the 200 day moving average of $7.17.

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) closed up +0.17 points or 2.44% at $7.15 with 0.8 mln shares exchanging hands. The firm had revenue of $1.59 million during the quarter, compared to analyst estimates of $1.54 million. Analyst established EPS growth expected to grow of 10.50% for this year and EPS growth for next year is likely to attain at 27.20%. It has outperformed by 89.88% the S&P500.The move comes after 7 months negative chart setup for the $344.61 million company. The target implies a 10.15% spike from where the shares are now trading. Wade G W & Inc. acquired a new stake in Tetraphase Pharmaceuticals in the first quarter valued at $138,000. "(TTPH) Cut to Sell at ValuEngine" was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and worldwide trademark and copyright laws.

Tetraphase Pharmaceuticals (NASDAQ TTPH) opened at 6.79 on Wednesday. Jacques Dumas, Chief ScientificOfficer let go of $41,928 worth of shares at an average price of $5.86 on Thursday the 17th. The stock has been active on the tape, now trading at $6.79, down from yesterday's close by -5.03%.

Turning to Barrick Gold Corporation (NYSE:ABX), its shares were trading at $18.22 a gain of $0.11, on the trading floor. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 5.50% of the company's stock.

Several hedge funds have recently added to or reduced their stakes in the company.

Ubs Group Ag cut its position by shedding 1,617 shares a decrease of 71.3% in the quarter. Vanguard Group Inc. now owns 1,638,789 shares of the biopharmaceutical company's stock worth $15,061,000 after acquiring an additional 230,420 shares during the last quarter. Dimensional Fund Advisors LP now owns 1,101,255 shares of the biopharmaceutical company's stock worth $7,853,000 after acquiring an additional 466,955 shares during the last quarter. As of the end of the quarter Pdt Partners, LLC had bought 34,665 shares growing its position 22.0%. Northern Trust Corp raised its position in shares of Tetraphase Pharmaceuticals by 4.8% during the second quarter. As of the end of the quarter Trexquant Investment Lp had disposed of 6,968 shares trimming its position 24.1%. Finally, Numeric Investors LLC raised its position in shares of Tetraphase Pharmaceuticals by 1,363.3% during the second quarter. Bank of New York Mellon Corp now owns 187,897 shares of the biopharmaceutical company's stock worth $1,726,000 after acquiring an additional 6,114 shares during the period. Following the completion of the transaction, the insider now directly owns 17,500 shares of the company's stock, valued at $105,000.

Some buy side analysts are also providing their Analysis on Tetraphase Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 4 analysts have given a Buy signal, 2 said it's a HOLD.



Like this

Latest


07 September 2017
Bustling Stock in Focus: United Technologies Corporation (NYSE:UTX)
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0.72, and a price to sales ratio of 1.41. As of quarter end Manufacturers Life Insurance Company, The had bought 915,489 shares growing its position 16,353.9%.

07 September 2017
North Korea's Latest Nuclear Test Seems To Have Caused Landslides
Still, some Chinese scientists worry the mountain might not hold up much longer if North Korea keeps testing. Japan has put it at 120 kilotons, eight times the size of the USA device that destroyed Hiroshima in 1945.

07 September 2017
Apple Hospitality REIT, Inc. (NYSE:APLE) Sees Significantly Higher Trading Volume
On Tuesday, August 22nd, Redd Hugh purchased 2,000 shares of Apple Hospitality REIT stock. (REIT) (NYSE:RHP) for 45,781 shares. Lithia Motors, Inc.is an operator of automotive franchises and a retailer of new and used vehicles and related services.

07 September 2017
The Plains Group Holdings, LP (PAGP) Downgraded by ValuEngine
TheStreet downgraded shares of Plains GP Holdings from a c rating to a d+ rating in a research note on Monday, August 7th. The company reported the earnings of $0.16/Share in the last quarter where the estimated EPS by analysts was $0.25/share.

07 September 2017
We have many military options
Trump has been tweeting throughout the day as he takes aim at North Korea, earlier this year promising "fire and fury". Security Council, whose members unanimously remain committed to the denuclearization of the Korean peninsula.

07 September 2017
Apriem Advisors Reduces Holdings in Cohen & Steers infrastucture Fund Inc (UTF)
The Fund's investment objective is high current income through investment in real estate and diversified preferred securities. Commonwealth Equity Svcs Incorporated has 0% invested in Cohen and Steers Global Income Builder (NYSE:INB) for 10,732 shares.

07 September 2017
The Symantec Corporation (SYMC) Shares Bought by Commerce Bank
The institutional investor owned 19,117 shares of the technology company's stock after selling 258 shares during the period. The technology company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.03.

07 September 2017
Trump says military action is not his 'first choice' on North Korea
President Donald Trump was scheduled to speak with with Chinese President Xi Jinping of China on Wednesday morning. Existing sanctions primarily aim to block North Korean exports, but imports are the regime's bigger vulnerability.

07 September 2017
Netflix taps Jonathan Pryce to play Pope Francis in The Pope
He is repped by UTA and Julian Belfrage Associates, LBI Entertainment reps Meirelles and McCarten is repped by ICM Partners. The drama conveys his reluctance to take the top post in 2013.

07 September 2017
Giants' Odell Beckham Jr. making progress, returns to practice field
And that's progress, since he hasn't been there since spraining his ankle during his lone preseason appearance on August 21.



Recommended